INtensity of OVarian Stimualtion and Euploid Embryos

PHASE4RecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

December 15, 2025

Study Completion Date

May 15, 2026

Conditions
Fertility
Interventions
DRUG

Follitropin-delta (Rekovelle) 20 mcg/day from D1

On day 2 or 3 of the menstrual cycle, daily injections of 20 mcg of Rekovelle (Stimulation Day 1) will be administered. Scan controls blood exams are performed on stimulation days 6, 8, 10 and, according to clinical needs, until trigger day. The dose will be the same during the whole course of stimulation and no dose adjustments will be performed.

DRUG

Follitropin-delta (Rekovelle) 15 mcg/day from D1

On day 2 or 3 of the menstrual cycle, daily injections of 15 mcg of Rekovelle (Stimulation Day 1) will be administered. Scan controls and blood exams are performed on stimulation days 6, 8, 10 and, according to clinical needs, until trigger day. The dose will be the same during the whole course of stimulation and no dose adjustments will be performed.

Trial Locations (1)

08028

RECRUITING

Hospital Universitario Quiron Dexeus, Barcelona

All Listed Sponsors
lead

Fundación Santiago Dexeus Font

OTHER